Cambridge Healthtech Institute’s 5th Annual

Fibrosis and Inflammation

Drug Discovery in NASH, Lung Fibrosis, Inflammatory Bowl Disease and Autoimmunity

September 27-28, 2023


Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge Healthtech Institute's Fibrosis and Inflammation conference continues its fifth year of focusing in the general area of fibrosis drug discovery and development by probing mechanisms and cellular molecules of fibrosis and related processes. Join fellow drug discovery researchers to also hear about progress in therapeutic modalities for diseases such as NASH, autoimmune diseases, lung and gut diseases and even some cancers, all of which have components of fibrosis and inflammation.


Who should attend: Immunologists, Immunology Discovery Biologists, Discovery Chemists, Scientists, Researchers, Directors of Research, Vice Presidents, CSOs from Biotech, Pharma and Academics in departments such as: Immunology, Inflammation, Fibrosis, Metabolism, Liver Disease, Lung Disease, Autoimmunity, Digestive Diseases.


Coverage will include, but is not limited to:


  • NASH clinical stage compounds, new strategies and their targets (THR-b, FXR, PPAR, FGF21 and more)
  • Integrins and other general fibrosis targets
  • Lung fibrosis (idiopathic fibrosis drug candidates)
  • Fibrosis of the gut (IBD, the microbiome)
  • Immuno-oncology and fibrosis: Emerging targets – TGFb, GPCRs, growth factors, ECM components and the tumor micro-environment
  • Crossover inflammation and fibrosis targets (ROCK, LOXL2)
  • 3D and other new cellular models for fibrosis


The deadline for priority consideration is March 17, 2023.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


Opportunities for Participation:



For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252



For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431